• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The role of epsilon-aminocaproic acid in reducing bleeding after cardiac operation: a double-blind randomized study.

作者信息

Vander Salm T J, Ansell J E, Okike O N, Marsicano T H, Lew R, Stephenson W P, Rooney K

机构信息

Department of Surgery, University of Massachusetts Medical Center, Worcester 01655.

出版信息

J Thorac Cardiovasc Surg. 1988 Mar;95(3):538-40.

PMID:3278170
Abstract

Sixty patients scheduled for elective coronary artery bypass graft operations were randomly assigned to receive epsilon-aminocaproic acid or placebo to test whether antifibrinolytic therapy would decrease postoperative bleeding. A small but significant decrease in bleeding was observed in the treated group without complications resulting from treatment with epsilon-aminocaproic acid.

摘要

相似文献

1
The role of epsilon-aminocaproic acid in reducing bleeding after cardiac operation: a double-blind randomized study.
J Thorac Cardiovasc Surg. 1988 Mar;95(3):538-40.
2
[Bleeding after extracorporeal circulation and epsilon-aminocaproic acid].[体外循环后出血与ε-氨基己酸]
Ann Fr Anesth Reanim. 1985;4(5):403-5. doi: 10.1016/S0750-7658(85)80269-0.
3
A double-blind, placebo-controlled trial of epsilon-aminocaproic acid for reducing blood loss in coronary artery bypass grafting surgery.一项关于ε-氨基己酸减少冠状动脉搭桥手术中失血的双盲、安慰剂对照试验。
J Am Coll Surg. 2006 Feb;202(2):216-22; quiz A44-5. doi: 10.1016/j.jamcollsurg.2005.10.001. Epub 2005 Dec 19.
4
[epsilon-Zinc acetamide caproate versus cimetidine in the treatment of peptic ulcer. Randomized study].ε-己酸锌乙酰胺与西咪替丁治疗消化性溃疡的对比。随机研究
Med Clin (Barc). 1985 Dec 14;85(20):831-4.
5
The effect of epsilon-aminocaproic acid and aprotinin on fibrinolysis and blood loss in patients undergoing primary, isolated coronary artery bypass surgery: a randomized, double-blind, placebo-controlled, noninferiority trial.ε-氨基己酸和抑肽酶对接受初次单纯冠状动脉搭桥手术患者纤溶及失血的影响：一项随机、双盲、安慰剂对照的非劣效性试验。
Anesth Analg. 2009 Jul;109(1):15-24. doi: 10.1213/ane.0b013e3181a40b5d.
6
The use of epsilon-aminocaproic acid to reduce bleeding following coronary artery revascularization.使用ε-氨基己酸减少冠状动脉血运重建术后出血。
Ala J Med Sci. 1977 Apr;14(2):162-4.
7
[Tooth extraction in patients suffering from hemophilia A under the cover of cryoprecipitates and epsilon-aminocaproic acid].[在冷沉淀和ε-氨基己酸覆盖下对甲型血友病患者进行拔牙]
Acta Haematol Pol. 1979 Apr-Jun;10(2):123-8.
8
[Effect on blood loss of the local use of epsilon-aminocaproic acid and ascorbic acid with an anesthetic (Novocain) during and after tonsillectomy].[扁桃体切除术中及术后局部使用ε-氨基己酸和抗坏血酸与麻醉剂（奴夫卡因）对失血的影响]
Zh Ushn Nos Gorl Bolezn. 1978 Jul-Aug(4):27-8.
9
Prophylactic tranexamic acid in elective, primary coronary artery bypass surgery using cardiopulmonary bypass.在使用体外循环的择期原发性冠状动脉搭桥手术中预防性使用氨甲环酸。
Eur J Cardiothorac Surg. 2004 Aug;26(2):311-7. doi: 10.1016/j.ejcts.2004.03.012.
10
Heparin-bonded cardiopulmonary bypass circuits reduce the rate of red blood cell transfusion during elective coronary artery bypass surgery.肝素结合型体外循环回路可降低择期冠状动脉搭桥手术期间红细胞输注率。
J Cardiothorac Vasc Anesth. 2005 Oct;19(5):608-11. doi: 10.1053/j.jvca.2005.07.003.

引用本文的文献

1
A Comparative Study to Determine the Effect of Intravenous Magnesium on Postoperative Bleeding after on Pump CABG in Patients Receiving Pre-Operative Aspirin.一项比较研究，旨在确定静脉注射镁对接受术前阿司匹林治疗的体外循环冠状动脉旁路移植术（on Pump CABG）患者术后出血的影响。
Indian J Anaesth. 2009 Apr;53(2):197-203.
2
The hemostatic defect of cardiopulmonary bypass.体外循环的止血缺陷。
J Thromb Thrombolysis. 2003 Dec;16(3):129-47. doi: 10.1023/B:THRO.0000024051.12177.e9.
3
Effect of tranexamic acid on blood loss reduction after cardiopulmonary bypass.
氨甲环酸对体外循环后减少失血的作用。
Jpn J Thorac Cardiovasc Surg. 2001 May;49(5):273-8. doi: 10.1007/BF02913132.
4
A risk-benefit assessment of aprotinin in cardiac surgical procedures.心脏手术中抑肽酶的风险效益评估。
Drug Saf. 1998 Jan;18(1):21-41. doi: 10.2165/00002018-199818010-00003.
5
Pharmacological approaches to reduce perioperative transfusion requirements in the aged.减少老年人围手术期输血需求的药理学方法。
Drugs Aging. 1995 Feb;6(2):91-104. doi: 10.2165/00002512-199506020-00002.
6
Antifibrinolytic therapy in cardiac surgery.心脏手术中的抗纤溶治疗。
Tex Heart Inst J. 1995;22(3):211-5.
7
Aprotinin. A review of its pharmacology and therapeutic efficacy in reducing blood loss associated with cardiac surgery.抑肽酶。其药理学及减少心脏手术相关失血的治疗效果综述。
Drugs. 1995 Jun;49(6):954-83. doi: 10.2165/00003495-199549060-00008.
8
Natural and synthetic antifibrinolytics in adult cardiac surgery: efficacy, effectiveness and efficiency.成人心脏手术中天然和合成抗纤溶药物：疗效、有效性和效率
Can J Anaesth. 1994 Nov;41(11):1104-12. doi: 10.1007/BF03015662.
9
Effective haemostasis during cardiac surgery.
Can J Anaesth. 1992 Apr;39(4):309-12. doi: 10.1007/BF03009038.
10
Natural and synthetic antifibrinolytics in cardiac surgery.心脏手术中的天然和合成抗纤溶药物
Can J Anaesth. 1992 Apr;39(4):353-65. doi: 10.1007/BF03009046.